Targeting virulence: a new paradigm for antimicrobial therapy (original) (raw)

• Palumbi, S.R. Humans as the world's greatest evolutionary force. Science 293, 1786–1790 (2001).
  Article PubMed CAS Google Scholar
• Young, J.A. & Collier, R.J. Anthrax toxin: receptor-binding, internalization, pore formation, and translocation. Annu. Rev. Biochem. 76, 243–265 (2007).
  Article PubMed CAS Google Scholar
• Boyden, E.D. & Dietrich, W.F. Nalp1b controls mouse macrophage susceptibility to anthrax lethal toxin. Nat. Genet. 38, 240–244 (2006).
  Article PubMed CAS Google Scholar
• Duesbery, N.S. et al. Proteolytic inactivation of MAP-kinase-kinase by anthrax lethal factor. Science 280, 734–737 (1998).
  Article PubMed CAS Google Scholar
• Vitale, G. et al. Anthrax lethal factor cleaves the N-terminus of MAPKKs and induces tyrosine/threonine phosphorylation of MAPKs in cultured macrophages. Biochem. Biophys. Res. Commun. 248, 706–711 (1998).
  Article PubMed CAS Google Scholar
• Panchal, R.G. et al. Chemical genetic screening identifies critical pathways in anthrax lethal toxin-induced pathogenesis. Chem. Biol. 14, 245–255 (2007).
  Article PubMed CAS Google Scholar
• During, R.L. et al. Anthrax lethal toxin paralyzes actin-based motility by blocking Hsp27 phosphorylation. EMBO J. 26, 2240–2250 (2007).
  Article PubMed PubMed Central CAS Google Scholar
• Rainey, G.J. & Young, J.A. Antitoxins: novel strategies to target agents of bioterrorism. Nat. Rev. Microbiol. 2, 721–726 (2004).
  Article PubMed Google Scholar
• Shoop, W.L. et al. Anthrax lethal factor inhibition. Proc. Natl. Acad. Sci. USA 102, 7958–7963 (2005).
  Article PubMed CAS PubMed Central Google Scholar
• Turk, B.E. et al. The structural basis for substrate and inhibitor selectivity of the anthrax lethal factor. Nat. Struct. Mol. Biol. 11, 60–66 (2004).
  Article PubMed CAS Google Scholar
• Krantz, B.A. et al. A phenylalanine clamp catalyzes protein translocation through the anthrax toxin pore. Science 309, 777–781 (2005).
  Article PubMed PubMed Central CAS Google Scholar
• Artenstein, A.W. et al. Chloroquine enhances survival in Bacillus anthracis intoxication. J. Infect. Dis. 190, 1655–1660 (2004).
  Article PubMed CAS Google Scholar
• Sanchez, A.M. et al. Amiodarone and bepridil inhibit anthrax toxin entry into host cells. Antimicrob. Agents Chemother 51, 2403–2411 (2007).
  Article PubMed PubMed Central CAS Google Scholar
• Moayeri, M., Wiggins, J.F., Lindeman, R.E. & Leppla, S.H. Cisplatin inhibition of anthrax lethal toxin. Antimicrob. Agents Chemother. 50, 2658–2665 (2006).
  Article PubMed PubMed Central CAS Google Scholar
• Ma, T. et al. Thiazolidinone CFTR inhibitor identified by high-throughput screening blocks cholera toxin-induced intestinal fluid secretion. J. Clin. Invest. 110, 1651–1658 (2002).
  Article PubMed PubMed Central CAS Google Scholar
• King, C.Y. & Barriere, S.L. Analysis of the in vitro interaction between vancomycin and cholestyramine. Antimicrob. Agents Chemother. 19, 326–327 (1981).
  Article PubMed PubMed Central CAS Google Scholar
• Galan, J.E. & Wolf-Watz, H. Protein delivery into eukaryotic cells by type III secretion machines. Nature 444, 567–573 (2006).
  Article PubMed CAS Google Scholar
• Kauppi, A.M., Nordfelth, R., Uvell, H., Wolf-Watz, H. & Elofsson, M. Targeting bacterial virulence: inhibitors of type III secretion in Yersinia. Chem. Biol. 10, 241–249 (2003).
  Article PubMed CAS Google Scholar
• Nordfelth, R., Kauppi, A.M., Norberg, H.A., Wolf-Watz, H. & Elofsson, M. Small-molecule inhibitors specifically targeting type III secretion. Infect. Immun. 73, 3104–3114 (2005).
  Article PubMed PubMed Central CAS Google Scholar
• Muschiol, S. et al. A small-molecule inhibitor of type III secretion inhibits different stages of the infectious cycle of Chlamydia trachomatis. Proc. Natl. Acad. Sci. USA 103, 14566–14571 (2006).
  Article PubMed CAS PubMed Central Google Scholar
• Bailey, L. et al. Small molecule inhibitors of type III secretion in Yersinia block the Chlamydia pneumoniae infection cycle. FEBS Lett. 581, 587–595 (2007).
  Article PubMed CAS Google Scholar
• Hudson, D.L. et al. Inhibition of type III secretion in Salmonella enterica serovar Typhimurium by small-molecule inhibitors. Antimicrob. Agents Chemother 51, 2631–2635 (2007).
  Article PubMed PubMed Central CAS Google Scholar
• Stevens, D.L., Gibbons, A.E., Bergstrom, R. & Winn, V. The Eagle effect revisited: efficacy of clindamycin, erythromycin, and penicillin in the treatment of streptococcal myositis. J. Infect. Dis. 158, 23–28 (1988).
  Article PubMed CAS Google Scholar
• Miller, M.B. & Bassler, B.L. Quorum sensing in bacteria. Annu. Rev. Microbiol. 55, 165–199 (2001).
  Article PubMed CAS Google Scholar
• Parsek, M.R., Val, D.L., Hanzelka, B.L., Cronan, J.E. Jr. & Greenberg, E.P. Acyl homoserine-lactone quorum-sensing signal generation. Proc. Natl. Acad. Sci. USA 96, 4360–4365 (1999).
  Article PubMed CAS PubMed Central Google Scholar
• Dong, Y.H., Xu, J.L., Li, X.Z. & Zhang, L.H. AiiA, an enzyme that inactivates the acylhomoserine lactone quorum-sensing signal and attenuates the virulence of Erwinia carotovora. Proc. Natl. Acad. Sci. USA 97, 3526–3531 (2000).
  Article PubMed CAS PubMed Central Google Scholar
• Dong, Y.H. et al. Quenching quorum-sensing-dependent bacterial infection by an N-acyl homoserine lactonase. Nature 411, 813–817 (2001).
  Article PubMed CAS Google Scholar
• Yang, F. et al. Quorum quenching enzyme activity is widely conserved in the sera of mammalian species. FEBS Lett. 579, 3713–3717 (2005).
  Article PubMed CAS Google Scholar
• Draganov, D.I. et al. Human paraoxonases (PON1, PON2, and PON3) are lactonases with overlapping and distinct substrate specificities. J. Lipid Res. 46, 1239–1247 (2005).
  Article PubMed CAS Google Scholar
• Muh, U. et al. Novel Pseudomonas aeruginosa quorum-sensing inhibitors identified in an ultra-high-throughput screen. Antimicrob. Agents Chemother. 50, 3674–3679 (2006).
  Article PubMed PubMed Central CAS Google Scholar
• Geske, G.D., Wezeman, R.J., Siegel, A.P. & Blackwell, H.E. Small molecule inhibitors of bacterial quorum sensing and biofilm formation. J. Am. Chem. Soc. 127, 12762–12763 (2005).
  Article PubMed CAS Google Scholar
• Smith, K.M., Bu, Y. & Suga, H. Induction and inhibition of Pseudomonas aeruginosa quorum sensing by synthtic autoinducer analogs. Chem. Biol. 10, 81–89 (2003).
  Article PubMed CAS Google Scholar
• Givskov, M. et al. Eukaryotic interference with homoserine lactone-mediated prokaryotic signalling. J. Bacteriol. 178, 6618–6622 (1996).
  Article PubMed PubMed Central CAS Google Scholar
• Manefield, M. et al. Halogenated furanones inhibit quorum sensing through accelerated LuxR turnover. Microbiology 148, 1119–1127 (2002).
  Article PubMed CAS Google Scholar
• Manefield, M., Welch, M., Givskov, M., Salmond, G.P. & Kjelleberg, S. Halogenated furanones from the red alga, Delisea pulchra, inhibit carbapenem antibiotic synthesis and exoenzyme virulence factor production in the phytopathogen Erwinia carotovora. FEMS Microbiol. Lett. 205, 131–138 (2001).
  Article PubMed CAS Google Scholar
• Hentzer, M. et al. Inhibition of quorum sensing in Pseudomonas aeruginosa biofilm bacteria by a halogenated furanone compound. Microbiology 148, 87–102 (2002).
  Article PubMed CAS Google Scholar
• Hentzer, M. et al. Attenuation of Pseudomonas aeruginosa virulence by quorum sensing inhibitors. EMBO J. 22, 3803–3815 (2003).
  Article PubMed PubMed Central CAS Google Scholar
• Wu, H. et al. Synthetic furanones inhibit quorum-sensing and enhance bacterial clearance in Pseudomonas aeruginosa lung infection in mice. J. Antimicrob. Chemother. 53, 1054–1061 (2004).
  Article PubMed CAS Google Scholar
• Yates, E.A. et al. N-acylhomoserine lactones undergo lactonolysis in a pH-, temperature-, and acyl chain length-dependent manner during growth of Yersinia pseudotuberculosis and Pseudomonas aeruginosa. Infect. Immun. 70, 5635–5646 (2002).
  Article PubMed PubMed Central CAS Google Scholar
• Muh, U. et al. A structurally unrelated mimic of a Pseudomonas aeruginosa acyl-homoserine lactone quorum-sensing signal. Proc. Natl. Acad. Sci. USA 103, 16948–16952 (2006).
  Article PubMed CAS PubMed Central Google Scholar
• Lyon, G.J., Wright, J.S., Christopoulos, A., Novick, R.P. & Muir, T.W. Reversible and specific extracellular antagonism of receptor-histidine kinase signaling. J. Biol. Chem. 277, 6247–6253 (2002).
  Article PubMed CAS Google Scholar
• Mayville, P. et al. Structure-activity analysis of synthetic autoinducing thiolactone peptides from Staphylococcus aureus responsible for virulence. Proc. Natl. Acad. Sci. USA 96, 1218–1223 (1999).
  Article PubMed CAS PubMed Central Google Scholar
• Wright, J.S. III, Jin, R. & Novick, R.P. Transient interference with staphylococcal quorum sensing blocks abscess formation. Proc. Natl. Acad. Sci. USA 102, 1691–1696 (2005).
  Article PubMed CAS PubMed Central Google Scholar
• Hung, D.T., Shakhnovich, E.A., Pierson, E. & Mekalanos, J.J. Small-molecule inhibitor of Vibrio cholerae virulence and intestinal colonization. Science 310, 670–674 (2005).
  Article PubMed CAS Google Scholar
• Gauthier, A. et al. Transcriptional inhibitor of virulence factors in enteropathogenic Escherichia coli. Antimicrob. Agents Chemother. 49, 4101–4109 (2005).
  Article PubMed PubMed Central CAS Google Scholar
• Sauer, F.G. et al. Chaperone-assisted pilus assembly and bacterial attachment. Curr. Opin. Struct. Biol. 10, 548–556 (2000).
  Article PubMed CAS Google Scholar
• Svensson, A. et al. Design and evaluation of pilicides: potential novel antibacterial agents directed against uropathogenic Escherichia coli. ChemBioChem 2, 915–918 (2001).
  Article PubMed CAS Google Scholar
• Pinkner, J.S. et al. Rationally designed small compounds inhibit pilus biogenesis in uropathogenic bacteria. Proc. Natl. Acad. Sci. USA 103, 17897–17902 (2006).
  Article PubMed CAS PubMed Central Google Scholar
• Lee, Y.M., Almqvist, F. & Hultgren, S.J. Targeting virulence for antimicrobial chemotherapy. Curr. Opin. Pharmacol. 3, 513–519 (2003).
  Article PubMed CAS Google Scholar
• Sassetti, C.M. & Rubin, E.J. Genetic requirements for mycobacterial survival during infection. Proc. Natl. Acad. Sci. USA 100, 12989–12994 (2003).
  Article PubMed CAS PubMed Central Google Scholar
• MacRae, C.A. & Peterson, R.T. Zebrafish-based small molecule discovery. Chem. Biol. 10, 901–908 (2003).
  Article PubMed CAS Google Scholar
• Peterson, R.T. et al. Chemical suppression of a genetic mutation in a zebrafish model of aortic coarctation. Nat. Biotechnol. 22, 595–599 (2004).
  Article PubMed CAS Google Scholar
• Stern, H.M. et al. Small molecules that delay S phase suppress a zebrafish bmyb mutant. Nat. Chem. Biol. 1, 366–370 (2005).
  Article PubMed CAS Google Scholar
• Davis, J.M. et al. Real-time visualization of _Mycobacterium_-macrophage interactions leading to initiation of granuloma formation in zebrafish embryos. Immunity 17, 693–702 (2002).
  Article PubMed CAS Google Scholar
• Neely, M.N., Pfeifer, J.D. & Caparon, M. Streptococcus-zebrafish model of bacterial pathogenesis. Infect. Immun. 70, 3904–3914 (2002).
  Article PubMed PubMed Central CAS Google Scholar
• van der Sar, A.M. et al. Zebrafish embryos as a model host for the real time analysis of Salmonella typhimurium infections. Cell. Microbiol. 5, 601–611 (2003).
  Article PubMed CAS Google Scholar
• Mukhopadhyay, A. & Peterson, R.T. Fishing for new antimicrobials. Curr. Opin. Chem. Biol. 10, 327–333 (2006).
  Article PubMed CAS Google Scholar
• Moy, T.I. et al. Identification of novel antimicrobials using a live-animal infection model. Proc. Natl. Acad. Sci. USA 103, 10414–10419 (2006).
  Article PubMed CAS PubMed Central Google Scholar
• Payne, D.J., Gwynn, M.N., Holmes, D.J. & Pompliano, D.L. Drugs for bad bugs: confronting the challenges of antibacterial discovery. Nat. Rev. Drug Discov. 6, 29–40 (2007).
  Article PubMed CAS Google Scholar
• Lipinski, C.A., Lombardo, F., Dominy, B.W. & Feeney, P.J. Experimental and computational approaches to estimate solubility and permeability in drug discovery and development settings. Adv. Drug Deliv. Rev. 46, 3–26 (2001).
  Article PubMed CAS Google Scholar
• Schreiber, S.L. Target-oriented and diversity-oriented organic synthesis in drug discovery. Science 287, 1964–1969 (2000).
  Article CAS PubMed Google Scholar
• Sarac, M.S., Peinado, J.R., Leppla, S.H. & Lindberg, I. Protection against anthrax toxemia by hexa-D-arginine in vitro and in vivo. Infect. Immun. 72, 602–605 (2004).
  Article PubMed PubMed Central CAS Google Scholar